
The costs of making things in space — and getting them back to earth — is high. But infrastructure to bring down the costs is being built.
Outpatient surgery can be up to 60% cheaper and produce better outcomes than hospital procedures, but the market is fragmented. Oliver Keown wants to fix that.
Some 46 corporate-backed startups had an exit in May, a handful at more than $1bn. But the market is still in a holding pattern.
Leaps by Bayer's head of healthcare venture investments, Lucio Iannone, is set to be managing director for diabetes-focused VC investor The T1D Fund.
Rehau New Ventures invests in mobility, manufacturing, medtech, raw materials and the built world.
Eba leaves founding partner position to take on a CFO role.
CFO Javier Rodriguez is taking Owen Lozman's place as co-head of Merck's corporate VC unit, where he will lead its technology investments.
Returns are great. Scaled innovations that move the needle are better.
Fresh from leading Cathay Capital's healthcare division, Hongjie Hu has joined Novo's investment arm as a growth-stage partner.
Guy's and St Thomas's and Kings College Hospital started the fund in 2021 to see if an NHS VC fund could succeed. Now it has partnerships and funding from US hospital groups.
April saw fewer corporate-backed startup exits than the high months of Q1 2025, due to a fall in M&A for healthcare and IT companies.
Investors in healthcare, hardware, climate tech and defence are feeling the impact of the Trump administration's policies.
US FDA and NIH cuts are expected to delay drug approvals and decrease grant funding, making it harder for young health sector companies to survive.
Tobias Egle has left his role working for the tech and biotech venture fund M Ventures after three years at the CVC.
UK smartphone camera component developer Cambridge Mechatronics’ latest round featured strategic investors Sony Ventures and Intel Capital.
Brendan Bulik-Sullivan, Crystal Huang, Frédérique Dame and Issi Rozen have been promoted from partner positions at the early-stage Alphabet fund.
Wana Schulze and Ivan Yoon will lead CVC investments at Telefónica’s seed and early-stage Brazilian subsidiaries.